Skip to main content
OpenTrials
Completed

NCT Number: NCT04811638

The Validity and Reliability Study of the Chelsea Critical Care Physical Assesment Tool

This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ICU Patients ICU Acquired Weakness

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Mehmet Burak Uyaroğlu

Istanbul, 34415, Turkey (Türkiye)

About this study

Survival has increased in the ICU due to technological developments , but physical disability after discharge has become an important problem. İntensive Care Unit Acquired Weakness(ICU-AW) is seen in most of the patients admitted in this unit. The biggest reasons for ICU-AW are; sepsis, multiple organ failure and prolonged mechanical ventilation. The use of measurement tools to evaluate disabilities during stay and after discharge in intensive care unit, is a subject that has been researched all over the world.. These measurement tools provide; monitoring and evaluation during the ICU admission and assessment efficacy of treatment in the unit. The Chelsea Critical Care Physical Assessment Tool(CPAX) has been shown to valid, reliable and to exhibited strong clinimetric properties. CPAx is a numerical measurement tool, rated according to the 6-point Guttman Scale, from complete dependence to independence and consist of ten physical function parameters. This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity. The protocol includes a pre-test of the Turkish version on 10 patients, a final revision, and a validation on a sample of 40 İCU patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Older than 18 years
  • Critical adult patients
  • Patients who were hospitalized for more than 48 hours in an ICU

Exclusion criteria

  • Unstable fracture
  • Limb deformities and dysfunction
  • Myasthenia gravis
  • Neuromuscular dysfunction
  • Patients who diagnosed COVİD-19

Treatment and study plan

Validation of the Chelsea Critical Care Physical Assesment Tools

Other

The validation of the CPAX tools will focus on the validity of constructs, internal consistency reliability and test-retest reliability. PFIT used for criterion validity.

Primary outcomes

  1. Chelsea Critical Care Physical Assesment Tools

    Time frame: three days

    The Chelsea critical care physical assessment (CPAx) is a measurement tool used to assess physical function in the ICU. The Chelsea critical care physical assessment (CPAx) tool is an outcome measure designed to assess 10 domains of physical ability: respiratory function, cough, bed mobility, supine to sitting on the edge of the bed, dynamic sitting, sit to stand, standing balance, transferring from bed to chair, stepping and grip strength.

    The validation of the CPAX tools will focus on the validity of constructs, internal consistency reliability and test-retest reliability.

Secondary outcomes

  1. Physical Function in Intensive Care Test

    Time frame: three days

    The PFIT is a test that measures function status of patients with a variety of conditions in the ICU. It includes 5 items: amount of assistance for sit-to-stand transfers, strength for shoulder flexion, strength for knee extension, marching in place, and an upper extremity endurance task of arm elevation to 90 degrees of shoulder flexion.

    PFIT used for criterion validity.

Sponsors and collaborators

Lead sponsor

Saglik Bilimleri Universitesi

Other

Collaborators

  • Medical Park Hospital Istanbul

Registry information

Official study title

The Validity and Reliability of the Turkish Version of the Chelsea Critical Care Physical Assesment Tool

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 23, 2021
Registry last updated
Aug 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.